India’s First Indigenous Biomedical Waste Plant Opens
WATER & WASTE

India’s First Indigenous Biomedical Waste Plant Opens

Union Minister Dr. Jitendra Singh inaugurated India’s first indigenous Automated Biomedical Waste Treatment Plant, ‘S?janam,’ at AIIMS New Delhi. Developed by CSIR-NIIST, the plant offers a sustainable alternative to incineration by disinfecting pathogenic waste without harmful emissions.

With an initial capacity to handle 400 kg of biomedical waste per day, ‘S?janam’ neutralizes odors and treats infectious materials like blood, urine, and laboratory disposables. The system, currently undergoing validation and regulatory approval, could revolutionize biomedical waste management in India.

India generates 743 tonnes of biomedical waste daily, according to a 2023 CPCB report. Traditional incineration poses health and environmental risks, making this new technology a crucial step in waste management. Third-party validation confirms its antimicrobial effectiveness, with studies suggesting treated material is even safer than organic fertilizers like vermicompost.

During the event, Singh also highlighted India’s recent scientific advancements, including indigenous DNA and HPV vaccines, the antibiotic Nafithromycin, and gene therapy trials. He outlined key government initiatives, such as Rs 500 billion for the Anusandhan National Research Foundation and Rs 200 billion for Bharat Small Modular Reactors.

With a growing focus on research and sustainability, ‘S?janam’ marks a significant milestone in India’s biomedical waste management efforts.

Union Minister Dr. Jitendra Singh inaugurated India’s first indigenous Automated Biomedical Waste Treatment Plant, ‘S?janam,’ at AIIMS New Delhi. Developed by CSIR-NIIST, the plant offers a sustainable alternative to incineration by disinfecting pathogenic waste without harmful emissions. With an initial capacity to handle 400 kg of biomedical waste per day, ‘S?janam’ neutralizes odors and treats infectious materials like blood, urine, and laboratory disposables. The system, currently undergoing validation and regulatory approval, could revolutionize biomedical waste management in India. India generates 743 tonnes of biomedical waste daily, according to a 2023 CPCB report. Traditional incineration poses health and environmental risks, making this new technology a crucial step in waste management. Third-party validation confirms its antimicrobial effectiveness, with studies suggesting treated material is even safer than organic fertilizers like vermicompost. During the event, Singh also highlighted India’s recent scientific advancements, including indigenous DNA and HPV vaccines, the antibiotic Nafithromycin, and gene therapy trials. He outlined key government initiatives, such as Rs 500 billion for the Anusandhan National Research Foundation and Rs 200 billion for Bharat Small Modular Reactors. With a growing focus on research and sustainability, ‘S?janam’ marks a significant milestone in India’s biomedical waste management efforts.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code